Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) insider Riccardo Perfetti sold 22,003 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $4.32, for a total transaction of $95,052.96. Following the sale, the insider now owns 1,009,534 shares of the company’s stock, valued at […]
Avoro Capital Advisors LLC boosted its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 690.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,555,555 shares of the biotechnology company’s stock after buying an additional 6,600,000 shares during the […]
Rhenman & Partners Asset Management AB acquired a new stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,500 shares of the company’s stock, valued at approximately $629,000. Several other hedge funds have […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a drop of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
ESSA Pharma Inc. (NASDAQ:EPIX – Free Report) (TSE:EPI) – Stock analysts at Zacks Small Cap cut their Q3 2024 EPS estimates for ESSA Pharma in a report released on Tuesday, May 28th. Zacks Small Cap analyst D. Bautz now forecasts that the company will post earnings per share of ($0.30) for the quarter, down from […]